pharmaphorum April 3, 2024
Phil Taylor

The FDA has cleared an artificial intelligence algorithm that can detect signs of heart failure in seconds using a digital stethoscope during a standard physical exam.

The algorithm was developed by digital stethoscope maker Eko Health in collaboration with the Mayo Clinic. It looks for low ejection fraction (EF), a reduction in outflow of blood from the heart to the aorta, which is present in approximately 50% of heart failure cases.

If LVEF is 40% or less a patient is considered to have heart failure with reduced ejection fraction (HFrEF), sometimes known as systolic heart failure, which generally has to be diagnosed in a hospital setting.

The Low EF AI means that some cases of heart failure could be spotted...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Digital Health, FDA, Govt Agencies, Patient / Consumer, Provider, Technology
OpenAI’s new GPT-4o lets people interact using voice or video in the same model
The Download: the future of chips, and investing in US AI
5 Common Mistakes That Risk Your Pharma AI Efforts
What’s next in chips
AI Explained: Deep Learning Lets AI Tackle Complex Tasks

Share This Article